Unknown

Dataset Information

Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration.


ABSTRACT:

Background

Tumor spreading is the major threat for cancer patients. The recently published anti-cancer drug salinomycin raised hope for an improved treatment by targeting therapy-refractory cancer stem cells. However, an unambiguous role of salinomycin against cancer cell migration and metastasis formation remains elusive.

Findings

We report that salinomycin effectively inhibits cancer cell migration in a variety of cancer types as determined by Boyden chamber assays. Additionally, cells were treated with doxorubicin at a concentration causing a comparable low cytotoxicity, emphasizing the anti-migratory potential of salinomycin. Moreover, single-cell tracking by time-lapse microscopy demonstrated a remarkable effect of salinomycin on breast cancer cell motility. Ultimately,

SUBMITTER: Kopp F 

PROVIDER: S-EPMC3909296 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature